Abbie Kelley
Psychiatric/Mental Health · Cedar Rapids, IANPI 1114510575
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 439 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 24.4% of the total. 2025 is the largest year on record at $2,095, 3.1 times the $687 reported in 2021. Among psychiatric/mental health clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 439 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$613
- Neurocrine Biosciences, Inc.$464
- Teva Pharmaceuticals USA, Inc.$407
- Corium, LLC$287
- plus $2K from 16 others
What the payments were for
- Food & beverage$6,38398%
- Education$1502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 129 | $1,596 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 77 | $1,204 |
| Otsuka America Pharmaceutical, Inc. | 37 | $613 |
| Neurocrine Biosciences, Inc. | 53 | $464 |
| Teva Pharmaceuticals USA, Inc. | 14 | $407 |
| Corium, LLC | 24 | $287 |
| Lundbeck LLC | 13 | $268 |
| Vanda Pharmaceuticals Inc. | 11 | $237 |
| Alkermes, Inc. | 12 | $229 |
| Ironshore Pharmaceuticals Inc. | 12 | $206 |
| Axsome Therapeutics, Inc. | 11 | $184 |
| Almatica Pharma LLC | 9 | $148 |
| Johnson & Johnson | 6 | $140 |
| E.r. Squibb & Sons, L.L.C. | 5 | $120 |
| Collegium Pharmaceutical, Inc. | 6 | $93 |
| Sunovion Pharmaceuticals Inc. | 5 | $78 |
| Idorsia Pharmaceuticals US Inc | 4 | $63 |
| Supernus Pharmaceuticals, Inc. | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Itamar Medical Inc | 1 | $37 |
| Tris Pharma Inc | 2 | $31 |
| Adlon Therapeutics L.p. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$125
How this compares
$6,533 in reported general payments places this provider in the 90th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Cedar Rapids
- Jennifer BradleyCedar Rapids$66K
- Amy MorinCedar Rapids$24K
- Natasha LashCedar Rapids$6K
- Kristina GatesCedar Rapids$6K
- Daniell DarbyshireCedar Rapids$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.